 | • レポートコード：D005-01861 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗喘息薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗喘息薬の種類別市場規模（長期管理薬、速効薬（レスキュー薬）、アレルギー性喘息薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abdi Ibrahim、Menarini、Innoviva、Ception Therapeutics、Mitsubishi Tanabe Pharma、Elan、Lonza、Sanofi、Novartis、Dong-A Socio Holdings、Sosei、Lonza、Regeneron Pharmaceuticals、Theravance Biopharma ・地域別グローバル市場分析 2015年-2020年 ・抗喘息薬の北米市場（アメリカ、カナダ、メキシコ） ・抗喘息薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗喘息薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗喘息薬の南米市場（ブラジル、アルゼンチン） ・抗喘息薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：長期管理薬、速効薬（レスキュー薬）、アレルギー性喘息薬 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti-Asthmatic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-Asthmatic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-Asthmatic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-Asthmatic Drugs market has been segmented into
Long-term Control Medications
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
By Application, Anti-Asthmatic Drugs has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Asthmatic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Asthmatic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Asthmatic Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-Asthmatic Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-Asthmatic Drugs Market Share Analysis
Anti-Asthmatic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Asthmatic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Asthmatic Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-Asthmatic Drugs are:
Abdi Ibrahim
Menarini
Innoviva
Ception Therapeutics
Mitsubishi Tanabe Pharma
Elan
Lonza
Sanofi
Novartis
Dong-A Socio Holdings
Sosei
Lonza
Regeneron Pharmaceuticals
Theravance Biopharma
Among other players domestic and global, Anti-Asthmatic Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Asthmatic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Asthmatic Drugs, with price, sales, revenue and global market share of Anti-Asthmatic Drugs in 2018 and 2019.
Chapter 3, the Anti-Asthmatic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Asthmatic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-Asthmatic Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-Asthmatic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-Asthmatic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Asthmatic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Long-term Control Medications
1.2.3 Quick-relief Medications (Rescue Medications)
1.2.4 Medications for Allergy-induced Asthma
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Asthmatic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Overview of Global Anti-Asthmatic Drugs Market
1.4.1 Global Anti-Asthmatic Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abdi Ibrahim
2.1.1 Abdi Ibrahim Details
2.1.2 Abdi Ibrahim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abdi Ibrahim SWOT Analysis
2.1.4 Abdi Ibrahim Product and Services
2.1.5 Abdi Ibrahim Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Menarini
2.2.1 Menarini Details
2.2.2 Menarini Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Menarini SWOT Analysis
2.2.4 Menarini Product and Services
2.2.5 Menarini Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Innoviva
2.3.1 Innoviva Details
2.3.2 Innoviva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Innoviva SWOT Analysis
2.3.4 Innoviva Product and Services
2.3.5 Innoviva Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ception Therapeutics
2.4.1 Ception Therapeutics Details
2.4.2 Ception Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ception Therapeutics SWOT Analysis
2.4.4 Ception Therapeutics Product and Services
2.4.5 Ception Therapeutics Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Mitsubishi Tanabe Pharma Details
2.5.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.5.4 Mitsubishi Tanabe Pharma Product and Services
2.5.5 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Elan
2.6.1 Elan Details
2.6.2 Elan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Elan SWOT Analysis
2.6.4 Elan Product and Services
2.6.5 Elan Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lonza SWOT Analysis
2.7.4 Lonza Product and Services
2.7.5 Lonza Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dong-A Socio Holdings
2.10.1 Dong-A Socio Holdings Details
2.10.2 Dong-A Socio Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dong-A Socio Holdings SWOT Analysis
2.10.4 Dong-A Socio Holdings Product and Services
2.10.5 Dong-A Socio Holdings Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sosei
2.11.1 Sosei Details
2.11.2 Sosei Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sosei SWOT Analysis
2.11.4 Sosei Product and Services
2.11.5 Sosei Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Lonza
2.12.1 Lonza Details
2.12.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Lonza SWOT Analysis
2.12.4 Lonza Product and Services
2.12.5 Lonza Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Regeneron Pharmaceuticals
2.13.1 Regeneron Pharmaceuticals Details
2.13.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Regeneron Pharmaceuticals SWOT Analysis
2.13.4 Regeneron Pharmaceuticals Product and Services
2.13.5 Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Theravance Biopharma
2.14.1 Theravance Biopharma Details
2.14.2 Theravance Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Theravance Biopharma SWOT Analysis
2.14.4 Theravance Biopharma Product and Services
2.14.5 Theravance Biopharma Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-Asthmatic Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-Asthmatic Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Asthmatic Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-Asthmatic Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-Asthmatic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Asthmatic Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-Asthmatic Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-Asthmatic Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-Asthmatic Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-Asthmatic Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-Asthmatic Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-Asthmatic Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-Asthmatic Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-Asthmatic Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-Asthmatic Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-Asthmatic Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-Asthmatic Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-Asthmatic Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-Asthmatic Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-Asthmatic Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-Asthmatic Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-Asthmatic Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-Asthmatic Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-Asthmatic Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-Asthmatic Drugs Price by Type (2015-2020)
11 Global Anti-Asthmatic Drugs Market Segment by Application
11.1 Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-Asthmatic Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-Asthmatic Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-Asthmatic Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-Asthmatic Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-Asthmatic Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-Asthmatic Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-Asthmatic Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-Asthmatic Drugs Market Forecast (2021-2025)
12.3 Anti-Asthmatic Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-Asthmatic Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-Asthmatic Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-Asthmatic Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-Asthmatic Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-Asthmatic Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-Asthmatic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Asthmatic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Asthmatic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abdi Ibrahim Basic Information, Manufacturing Base and Competitors
Table 8. Abdi Ibrahim Anti-Asthmatic Drugs Major Business
Table 9. Abdi Ibrahim Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Abdi Ibrahim SWOT Analysis
Table 11. Abdi Ibrahim Anti-Asthmatic Drugs Product and Services
Table 12. Abdi Ibrahim Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Menarini Basic Information, Manufacturing Base and Competitors
Table 14. Menarini Anti-Asthmatic Drugs Major Business
Table 15. Menarini Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Menarini SWOT Analysis
Table 17. Menarini Anti-Asthmatic Drugs Product and Services
Table 18. Menarini Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Innoviva Basic Information, Manufacturing Base and Competitors
Table 20. Innoviva Anti-Asthmatic Drugs Major Business
Table 21. Innoviva Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Innoviva SWOT Analysis
Table 23. Innoviva Anti-Asthmatic Drugs Product and Services
Table 24. Innoviva Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ception Therapeutics Basic Information, Manufacturing Base and Competitors
Table 26. Ception Therapeutics Anti-Asthmatic Drugs Major Business
Table 27. Ception Therapeutics Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Ception Therapeutics SWOT Analysis
Table 29. Ception Therapeutics Anti-Asthmatic Drugs Product and Services
Table 30. Ception Therapeutics Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Major Business
Table 33. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Mitsubishi Tanabe Pharma SWOT Analysis
Table 35. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Product and Services
Table 36. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Elan Basic Information, Manufacturing Base and Competitors
Table 38. Elan Anti-Asthmatic Drugs Major Business
Table 39. Elan Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Elan SWOT Analysis
Table 41. Elan Anti-Asthmatic Drugs Product and Services
Table 42. Elan Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Lonza Basic Information, Manufacturing Base and Competitors
Table 44. Lonza Anti-Asthmatic Drugs Major Business
Table 45. Lonza Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Lonza SWOT Analysis
Table 47. Lonza Anti-Asthmatic Drugs Product and Services
Table 48. Lonza Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sanofi Basic Information, Manufacturing Base and Competitors
Table 50. Sanofi Anti-Asthmatic Drugs Major Business
Table 51. Sanofi Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Sanofi SWOT Analysis
Table 53. Sanofi Anti-Asthmatic Drugs Product and Services
Table 54. Sanofi Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Anti-Asthmatic Drugs Major Business
Table 57. Novartis Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Novartis SWOT Analysis
Table 59. Novartis Anti-Asthmatic Drugs Product and Services
Table 60. Novartis Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Dong-A Socio Holdings Basic Information, Manufacturing Base and Competitors
Table 62. Dong-A Socio Holdings Anti-Asthmatic Drugs Major Business
Table 63. Dong-A Socio Holdings Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Dong-A Socio Holdings SWOT Analysis
Table 65. Dong-A Socio Holdings Anti-Asthmatic Drugs Product and Services
Table 66. Dong-A Socio Holdings Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sosei Basic Information, Manufacturing Base and Competitors
Table 68. Sosei Anti-Asthmatic Drugs Major Business
Table 69. Sosei Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Sosei SWOT Analysis
Table 71. Sosei Anti-Asthmatic Drugs Product and Services
Table 72. Sosei Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Lonza Basic Information, Manufacturing Base and Competitors
Table 74. Lonza Anti-Asthmatic Drugs Major Business
Table 75. Lonza Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Lonza SWOT Analysis
Table 77. Lonza Anti-Asthmatic Drugs Product and Services
Table 78. Lonza Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Major Business
Table 81. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Regeneron Pharmaceuticals SWOT Analysis
Table 83. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Product and Services
Table 84. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 86. Theravance Biopharma Anti-Asthmatic Drugs Major Business
Table 87. Theravance Biopharma Anti-Asthmatic Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Theravance Biopharma SWOT Analysis
Table 89. Theravance Biopharma Anti-Asthmatic Drugs Product and Services
Table 90. Theravance Biopharma Anti-Asthmatic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Anti-Asthmatic Drugs Sales by Manufacturer (2018-2019) (K Doses)
Table 92. Global Anti-Asthmatic Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Anti-Asthmatic Drugs Sales by Regions (2015-2020) (K Doses)
Table 94. Global Anti-Asthmatic Drugs Sales Market Share by Regions (2015-2020)
Table 95. Global Anti-Asthmatic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Anti-Asthmatic Drugs Sales by Countries (2015-2020) (K Doses)
Table 97. North America Anti-Asthmatic Drugs Sales Market Share by Countries (2015-2020)
Table 98. North America Anti-Asthmatic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020)
Table 100. Europe Anti-Asthmatic Drugs Sales by Countries (2015-2020) (K Doses)
Table 101. Europe Anti-Asthmatic Drugs Sales Market Share by Countries (2015-2020)
Table 102. Europe Anti-Asthmatic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Anti-Asthmatic Drugs Sales by Regions (2015-2020) (K Doses)
Table 104. Asia-Pacific Anti-Asthmatic Drugs Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Anti-Asthmatic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Anti-Asthmatic Drugs Sales by Countries (2015-2020) (K Doses)
Table 107. South America Anti-Asthmatic Drugs Sales Market Share by Countries (2015-2020)
Table 108. South America Anti-Asthmatic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Anti-Asthmatic Drugs Sales by Countries (2015-2020) (K Doses)
Table 111. Middle East & Africa Anti-Asthmatic Drugs Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Anti-Asthmatic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020)
Table 114. Global Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 115. Global Anti-Asthmatic Drugs Sales Share by Type (2015-2020)
Table 116. Global Anti-Asthmatic Drugs Revenue by Type (2015-2020) (USD Million)
Table 117. Global Anti-Asthmatic Drugs Revenue Share by Type (2015-2020)
Table 118. Global Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 119. Global Anti-Asthmatic Drugs Sales Share by Application (2015-2020)
Table 120. Global Anti-Asthmatic Drugs Sales Forecast by Regions (2021-2025) (K Doses)
Table 121. Global Anti-Asthmatic Drugs Market Share Forecast by Regions (2021-2025)
Table 122. Global Anti-Asthmatic Drugs Sales Forecast by Type (2021-2025) (K Doses)
Table 123. Global Anti-Asthmatic Drugs Market Share Forecast by Type (2021-2025)
Table 124. Global Anti-Asthmatic Drugs Sales Forecast by Application (2021-2025)
Table 125. Global Anti-Asthmatic Drugs Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-Asthmatic Drugs Picture
Figure 2. Global Sales Market Share of Anti-Asthmatic Drugs by Type in 2019
Figure 3. Long-term Control Medications Picture
Figure 4. Quick-relief Medications (Rescue Medications) Picture
Figure 5. Medications for Allergy-induced Asthma Picture
Figure 6. Anti-Asthmatic Drugs Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacy Picture
Figure 8. Retail Pharmacy Picture
Figure 9. Online Pharmacy Picture
Figure 10. Global Anti-Asthmatic Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Anti-Asthmatic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Anti-Asthmatic Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Anti-Asthmatic Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Anti-Asthmatic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Anti-Asthmatic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 36. Global Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Anti-Asthmatic Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Anti-Asthmatic Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Anti-Asthmatic Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Anti-Asthmatic Drugs Sales Market Share by Countries in 2018
Figure 47. North America Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Anti-Asthmatic Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Canada Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Mexico Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Europe Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Anti-Asthmatic Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. UK Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. France Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Italy Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Asia-Pacific Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Anti-Asthmatic Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Anti-Asthmatic Drugs Revenue Market Share by Regions 2019
Figure 63. China Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Korea Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. India Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Southeast Asia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. South America Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Anti-Asthmatic Drugs Sales Market Share by Countries in 2019
Figure 70. South America Anti-Asthmatic Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Middle East and Africa Anti-Asthmatic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Egypt Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Turkey Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. South Africa Anti-Asthmatic Drugs Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Global Anti-Asthmatic Drugs Sales and Growth Rate (2021-2025) (K Doses)
Figure 82. Global Anti-Asthmatic Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Anti-Asthmatic Drugs Market Forecast (2021-2025) (K Doses)
Figure 84. Europe Sales Anti-Asthmatic Drugs Market Forecast (2021-2025) (K Doses)
Figure 85. Asia-Pacific Sales Anti-Asthmatic Drugs Market Forecast (2021-2025) (K Doses)
Figure 86. South America Sales Anti-Asthmatic Drugs Market Forecast (2021-2025) (K Doses)
Figure 87. Middle East & Africa Sales Anti-Asthmatic Drugs Market Forecast (2021-2025) (K Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
自殺防止薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Suicide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 3696 million by 2025, from USD 3384.6 million in 2019. The Anti-Suicide Drugs …- 皮膚科用OTC薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology OTC medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology OTC m…
- 小児科用抗てんかん薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-epileptic Drugs for Pediatrics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 839.2 million by 2025, from USD 709.5 million in 2019. The An…
- 化学療法誘発悪心＆嘔吐（CINV）用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- コリン作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cholinergic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cholinergic Drugs market re…